An increasing number of wound care centers have elected to add hyperbaric medicine to their otherwise comprehensive array of therapeutic options. In carefully selected lower extremity lesions that have failed to respond to available care, hyperbaric oxygen (HBO) therapy can prove beneficial. Perhaps more importantly, the introduction of hyperbaric medicine will greatly increase referral volumes for a unique condition not otherwise seen in the traditional wound center. There are subsets of wound care deficient patients for which HBO therapy has evolved to represent standard care. They involve patients who have suffered cancer, have been treated with radiotherapy, have done well from an oncology standpoint, but now experience late radiotherapy complications. These vascular-derived insults occur across the anatomic spectrum. They are difficult to resolve conventionally, involve significant morbidity, and in some cases result in loss of organ or structure.  Uniquely, HBO therapy is disease-modifying in the management of late radiotherapy complications. This is in contrast to other interventions  that are commonly directed at relief of symptoms.

​

NBS carefully guides client institutions through all phases of hyperbaric medicine service implementation. Program planning, facility design, capital equipment acquisition, documentation, protocols and policies, training, skills maintenance, and quality assurance aspects are coordinated and optimized. Once the hyperbaric service is operational, NBS remains available to ensure that treatments are optimized in safe and effective manner.